Primaquine 26.3MG 100S
Ended Awarded Last action
- Contract number
- SPE2DX26FPFWB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $9,522
Award facts
- Contract value 100% obligated
- $9,521.84 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $9,521.84 to DMS Pharmaceutical Group Inc. for 100 units of Primaquine 26.3mg, with a completion date of December 1, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order represents one of numerous purchases issued to DMS Pharmaceutical Group under its broader prime vendor contract established with the Defense Logistics Agency.
This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) designated SPE2DR, which was awarded on November 13, 2025, as part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC carries a $499.999 billion ceiling and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support Department of Defense healthcare operations globally, with Primaquine—an antimalarial medication—representing part of the company's diverse pharmaceutical supply portfolio serving military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DX26FPFWB?
SPE2DX26FPFWB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on December 1, 2025.
How much is contract SPE2DX26FPFWB worth?
The government has obligated $9,522 on SPE2DX26FPFWB.
Is contract SPE2DX26FPFWB an order under another contract?
Yes. SPE2DX26FPFWB is a delivery order under SPE2DX15D9762, an indefinite delivery contract.
Was contract SPE2DX26FPFWB competed?
The extent of competition for SPE2DX26FPFWB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award